Perspective Therapeutics (FRA:AAJ0) Total Stockholders Equity : €263.30 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Total Stockholders Equity?

Perspective Therapeutics's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €263.30 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Perspective Therapeutics's Book Value per Share for the quarter that ended in Mar. 2025 was €3.56. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Perspective Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.01.

Perspective Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Perspective Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Total Stockholders Equity Chart

Perspective Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

5.08

55.95

57.97

68.94

277.59

Perspective Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															211.50	316.79	295.95	277.59	263.30

Perspective Therapeutics (FRA:AAJ0) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Perspective Therapeutics's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(263.297	-	0)	/	74.051
	=	3.56

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Perspective Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.956	+	2.576)	/	263.297
	=	0.01

Perspective Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ0) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ0:Germany

Address

2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Perspective Therapeutics Headlines

No Headlines